| 序號 |
年度 |
題目 |
出處 |
藥師 |
SCI |
| 1 |
115
|
Career adaptability of pharmacy students in Taiwan: A qualitative study
|
Currents in Pharmacy Teaching and Learning
|
李銘嘉
|
是
|
| 2 |
115
|
Career development barriers encountered by Taiwanese pharmacy students: A qualitative study across levels of career adaptability
|
Currents in Pharmacy Teaching and Learning
|
李銘嘉
|
是
|
| 3 |
115
|
Concurrent Chinese and Western medication use and risk of acute exacerbations in chronic obstructive pulmonary disease: A national cohort study
|
Integrative Medicine Research
|
李銘嘉
|
是
|
| 4 |
115
|
The efficacy of metformin for pain, function, and quality of life in knee osteoarthritis: A systematic review and meta-analysis
|
Seminars in Arthritis and Rheumatism
|
李銘嘉
|
是
|
| 5 |
115
|
Baxdrostat:難治性高血壓治療進展
|
臺灣臨床藥學雜誌 2025;33(3):209-217。
|
王建贏
|
否
|
| 6 |
115
|
Statin Use and the Risks of Delirium and Short-Term Mortality in Hospitalized Adults: An Updated Systematic Review and Meta-Analysis
|
Biomedicines, 14(10), 2291.
|
李銘嘉
|
是
|
| 7 |
115
|
The Pharyngeal Sanctuary: A Challenge for Zoliflodacin (Correspondence)
|
Lancet. 2026; 407(10541): 1781.
|
王建贏
|
是
|
| 8 |
115 |
透析病人心血管預防:MR antagonist 最新證據
|
臺灣臨床藥學雜誌 2025;33(3):209-217。
|
王建贏
|
否
|
| 9 |
115 |
慢性手部濕疹治療新進展:delgocitinib |
臺灣臨床藥學雜誌 2025;33(4):245-254。
|
王建贏
|
否
|
| 10 |
115 |
嬰兒 RSV 預防新型單株抗體臨床應用 |
臺灣臨床藥學雜誌 2025;33(3):161-169。
|
許珊瑜
|
否
|
| 11 |
114
|
Reduction in ambient PM2.5 associated with decreased risk of dialysis and mortality among patients with advanced chronic kidney disease: A population-based retrospective cohort study in Taiwan.
|
Ecotoxicology and Environmental Safety
|
李銘嘉
|
是
|
| 12 |
114
|
Superiority of Denosumab Over Bisphosphonates in Preventing and Treating Glucocorticoid-Induced Osteoporosis: A Systematic Review and Meta-Analysis with GRADE Quality Assessment
|
Frontiers in Endocrinology
|
王建贏
|
是
|
| 13 |
114
|
Possible association of statin use with the risk of depression: An up-to-date systematic review and meta-analysis
|
Gen Hosp Psychiatry
|
李銘嘉
|
是
|
| 14 |
114
|
Prediabetes as an indication for GLP 1 therapy. Clarifying evidence thresholds and clinical guardrails
|
International Journal of Obesity
|
王建贏
|
是
|
| 15 |
114
|
GLP-1 receptor agonists and diabetic retinopathy: comment on a case report
|
Journal of the American Pharmacists Association
|
王建贏
|
是
|